Literature DB >> 155876

Cytotoxic effects of activated human monocytes and lymphocytes to anti-D-treated human erythrocytes in vitro.

B Randazzo, T Hirschberg, H Hirschberg.   

Abstract

Incubation of human monocytes, derived from peripheral blood, with cell-free supernatants from mixed lymphocyte cultures resulted in morphological and functional changes in the mature macrophages. Activation of monocyte-derived macrophages by these factors resulted in a significant increase in their capacity to lyse anti-D-treated human erythrocytes. The lytic activity of both normal and activated macrophages appeared to be independent of erythrophagocytosis. T lymphocytes activated by either allogeneic cells or the mitogen phytohaemagglutinin were not cytolytic to treated erythrocytes even at high effector to target cell ratios.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 155876     DOI: 10.1111/j.1365-3083.1979.tb03173.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  4 in total

1.  Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells.

Authors:  S J Rüegg; T W Jungi
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

2.  The antibody-independent cytotoxic activity of normal circulating human leucocytes. I. Lysis of target cells by monocytes and neutrophils in a non-phagocytic pathway.

Authors:  D Banerjee; L Fernando; S Sklar; M Richter
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

3.  Activation of monocyte and granulocyte antibody-dependent cytotoxicity by phorbol myristate acetate.

Authors:  D K Klassen; P R Conkling; A L Sagone
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

4.  Enhanced K-cell activity in the peripheral blood of patients with malignant disease.

Authors:  T Bakács; P Czanik; I Kimber; G Ringwald; M Moore; E Abrahám
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.